Biomarker-stratified efficacy and safety of biologics in systemic lupus erythematosus: a systematic review and meta-analysis

Objective Biologics for systemic lupus erythematosus (SLE) demonstrate variable treatment responses across trials. We evaluated baseline biomarkers as predictors of response to guide personalised therapy selection.Methods We searched PubMed, OVID, Scopus, Cochrane and PsycInfo (January 2000–October...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Ahmed Y Azzam, Safi G Alqatari, Mohanad A Alkuwaiti, Faisal A Al-Harbi, Marj M Alabdullah, Adel A Zeidan, Noor H AlYousef, Mohammed A Alsaad, Rena Y Abualjamal, Feras Ahmed Alkuwaiti, Abdullah A Al-Abdulwahab, Hajer Musaab AlZuhair, Danya Y AlNujaidi, Nora A Alasaker, Manal A Hasan
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMJ Publishing Group 2026-03-01
Rangatū:	Lupus Science and Medicine
Urunga tuihono:	https://lupus.bmj.com/content/13/1/e001920.full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!